<?xml version="1.0" encoding="UTF-8"?>
<p id="p0295">The antiviral activity of decitabine has been shown mostly in HIV treatment. Similar to the previously described synergistic effect of azacytidine with resveratrol, the combination of decitabine and resveratrol significantly reduced the levels of HIV-1 reverse transcription products (
 <xref rid="bib83" ref-type="bibr">Rawson et al., 2016b</xref>). Another study indicated that the combination of gemcitabine and decitabine at concentrations much lower than those used in cancer treatment synergistically lowered HIV-1 infectivity by 73% and significantly increased the mutation frequency (
 <xref rid="bib18" ref-type="bibr">Clouser et al., 2010</xref>).
</p>
